KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres
KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeresA method for engineering human cells with distinct karyotypes of interest enables interrogation of a specific aneuploidy in the context of cancer.A method for engineering human cells with distinct karyotypes of interest enables interrogation of a specific aneuploidy in the context of cancer.Nazario Bosco, Aleah Goldberg, Xin Zhao, Joseph C. Mays, Pan Cheng, Adam F. Johnson, Joy J. Bianchi, Cecilia Toscani, Elena Di Tommaso, Lizabeth Katsnelson, Dania Annuar, Sally Mei, Roni E. Faitelson, Ilan Y. Pesselev, Kareem S. Mohamed, Angela Mermerian, Elaine M. Camacho-Hernandez, Courtney A. Gionco, Julie Manikas, Yi-Shuan Tseng, Zhengxi Sun, Somayeh Fani, Sarah Keegan, Scott M. Lippman, David Fenyö, Simona Giunta, Stefano Santaguida, Teresa Davolihttps://www.cell.com/cell/fulltext/S0092-8674(23)00326-4?rss=yeshttp://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignApril 19, 2023
Powered by WPeMatico